Jasper Therapeutics, Inc.
JSPR- 交易所
- Nasdaq
- 產業
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001788028
其他股別JSPRW
內部人交易
每一列是一份 Form 4 申報裡同一種交易的合計。預設只顯示公開市場買進（P）與賣出（S）；要看公司授予、行使選擇權等其他代碼，請調整篩選條件。
| 申報時間（美東） | 交易日 | 內部人 | 交易 | 股數 | 均價 | 金額 | 交易後持股 | 持股變化 | 申報 |
|---|---|---|---|---|---|---|---|---|---|
| 2026/7/2219:10 ET | 2026/7/20 | Ros Matthew E營運長 | P買進Voting Common Stock · 衍生 | +5.37 萬 | – | – | 881 | – | SEC |
| 2026/7/2020:38 ET | 2026/7/20 | Crutcher Patrick J董事 | P買進Voting Common Stock · 衍生 | +888 | – | – | 888 | – | SEC |
| 2025/9/24 | 2025/9/22 | WIGGANS THOMAS G董事 | P買進Voting Common Stock | +4.1 萬 | $2.43 | +$9.96 萬 | 4.1 萬 | 新建立 | SEC |
| 2025/9/24 | 2025/9/22 | WIGGANS THOMAS G董事 | P買進Voting Common Stock · 衍生 | +4.1 萬 | – | – | 4.1 萬 | – | SEC |
| 2025/9/24 | 2025/9/22 | Lucas Svetlana董事 | P買進Voting Common Stock | +2 萬 | $2.43 | +$4.86 萬 | 2 萬 | 新建立 | SEC |
| 2025/9/24 | 2025/9/22 | Lucas Svetlana董事 | P買進Voting Common Stock · 衍生 | +2 萬 | – | – | 2 萬 | – | SEC |
| 2025/9/24 | 2025/9/22 | MARTELL RON總裁、執行長 | P買進Voting Common Stock | +4.1 萬 | $2.43 | +$9.96 萬 | 7.41 萬 | +123.8% | SEC |
| 2025/9/24 | 2025/9/22 | MARTELL RON總裁、執行長 | P買進Voting Common Stock · 衍生 | +4.1 萬 | – | – | 4.1 萬 | – | SEC |
| 2025/9/24 | 2025/9/22 | Shizuru Judith Anne董事 | P買進Voting Common Stock | +4.1 萬 | $2.43 | +$9.96 萬 | 15.69 萬 | +35.4% | SEC |
| 2025/9/24 | 2025/9/22 | Shizuru Judith Anne董事 | P買進Voting Common Stock · 衍生 | +4.1 萬 | – | – | 4.1 萬 | – | SEC |
| 2024/12/12 | 2024/12/12 | Mahal Jeetinder Singh營運長 | S賣出Voting Common Stock | −900 | $22.11 | −$1.99 萬 | 2.5 萬 | −3.5% | SEC10b5-1 |
| 2024/9/12 | 2024/9/12 | Mahal Jeetinder Singh營運長 | S賣出Voting Common Stock | −900 | $21.23 | −$1.91 萬 | 2.5 萬 | −3.5% | SEC10b5-1 |
| 2024/6/12 | 2024/6/12 | Mahal Jeetinder Singh營運長 | S賣出Voting Common Stock | −900 | $24.16 | −$2.17 萬 | 2.5 萬 | −3.5% | SEC10b5-1 |
| 2024/3/12 | 2024/3/12 | Mahal Jeetinder Singh營運長 | S賣出Voting Common Stock | −900 | $26.44 | −$2.38 萬 | 2.5 萬 | −3.5% | SEC |
| 2024/2/1218:23 ET | 2024/2/8 | TC Group, LLC 等 10 人持股 10% 以上大股東 | P買進Voting Common Stock | +19 萬 | $12.95 | +$246.05 萬 | 106.62 萬 | +21.7% | SEC |
| 2024/2/920:40 ET | 2024/2/8 | VENKATARAMAN BALAJI 等 9 人持股 10% 以上大股東 | P買進Common Stock, par value $0.0001 per share | +35 萬 | $12.95 | +$453.25 萬 | 118.85 萬 | +41.7% | SEC |
| 2023/11/30 | 2023/11/28 | WIGGANS THOMAS G董事 | P買進Voting Common Stock | +1 萬 | $0.65 | +$6,500 | 5 萬 | +25.0% | SEC |
| 2023/11/22 | 2023/11/21 | WIGGANS THOMAS G董事 | P買進Voting Common Stock | +1 萬 | $0.64 | +$6,400 | 4 萬 | +33.3% | SEC |
| 2023/11/20 | 2023/11/16–11/20 | WIGGANS THOMAS G董事 | P買進Voting Common Stock | +3 萬 | $0.61 | +$1.83 萬 | 3 萬 | 新建立 | SEC |
| 2023/10/13 | 2023/10/13 | Lis William董事 | S賣出Voting Common Stock | −7,965 | $0.85 | −$6,770.25 | 5.35 萬 | −13.0% | SEC10b5-1 |
| 2023/6/13 | 2023/6/13 | Mahal Jeetinder Singh見申報附註 | S賣出Voting Common Stock | −9,000 | $1.66 | −$1.49 萬 | 28.72 萬 | −3.0% | SEC10b5-1 |
| 2023/4/14 | 2023/4/14 | French Anna Louise董事 | S賣出Voting Common Stock | −7,000 | $1.48 | −$1.04 萬 | 2.38 萬 | −22.8% | SEC |
| 2023/4/14 | 2023/4/13 | EMSTER KURT VON董事 | S賣出Voting Common Stock | −9,075 | $1.49 | −$1.35 萬 | 2.12 萬 | −30.0% | SEC |
| 2023/4/14 | 2023/4/13 | Lis William董事 | S賣出Voting Common Stock | −8,500 | $1.44 | −$1.22 萬 | 6.15 萬 | −12.1% | SEC |
| 2023/4/1119:55 ET | 2023/1/27 | MCDADE MARK 等 4 人持股 10% 以上大股東 | P買進Voting Common Stock | +266.67 萬 | $1.50 | +$400 萬 | 851.96 萬 | +45.6% | SEC |
| 2023/1/3117:24 ET | 2023/1/27 | TC Group, LLC 等 9 人持股 10% 以上大股東 | P買進Voting Common Stock | +313.33 萬 | $1.50 | +$470 萬 | 876.19 萬 | +55.7% | SEC |
| 2023/1/2617:49 ET | 2023/1/25 | ROCHE HOLDING LTD 等 2 人持股 10% 以上大股東 | S賣出Voting Common Stock | −7.5 萬 | $1.89 | −$14.18 萬 | 454.96 萬 | −1.6% | SEC |
| 2022/6/28 | 2022/6/24–6/27 | Lis William董事 | S賣出Voting Common Stock | −4.95 萬 | $2.05 | −$10.14 萬 | 4.05 萬 | −55.0% | SEC |